Wasatch Advisors Inc. lifted its holdings in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 20.4% in the first quarter, HoldingsChannel reports. The fund owned 96,474 shares of the company’s stock after purchasing an additional 16,363 shares during the period. Wasatch Advisors Inc.’s holdings in Tabula Rasa HealthCare were worth $5,443,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in the stock. TD Asset Management Inc. bought a new position in shares of Tabula Rasa HealthCare during the first quarter valued at $824,000. Mason Street Advisors LLC increased its holdings in shares of Tabula Rasa HealthCare by 6.8% during the first quarter. Mason Street Advisors LLC now owns 5,632 shares of the company’s stock valued at $318,000 after acquiring an additional 357 shares in the last quarter. Cadence Capital Management LLC increased its holdings in shares of Tabula Rasa HealthCare by 41.7% during the first quarter. Cadence Capital Management LLC now owns 50,462 shares of the company’s stock valued at $2,847,000 after acquiring an additional 14,854 shares in the last quarter. Independent Advisor Alliance bought a new position in shares of Tabula Rasa HealthCare during the first quarter valued at $588,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in shares of Tabula Rasa HealthCare by 3.3% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,019 shares of the company’s stock valued at $340,000 after acquiring an additional 194 shares in the last quarter. Institutional investors own 82.79% of the company’s stock.
Several equities analysts have recently weighed in on TRHC shares. Cantor Fitzgerald restated a “buy” rating and set a $99.00 price target on shares of Tabula Rasa HealthCare in a report on Thursday, February 28th. Zacks Investment Research cut Tabula Rasa HealthCare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 8th. BidaskClub raised Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a research report on Tuesday, May 7th. ValuEngine cut Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research report on Monday, May 13th. Finally, Guggenheim started coverage on Tabula Rasa HealthCare in a research report on Wednesday, April 17th. They set a “neutral” rating and a $58.00 price objective on the stock. Five analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $82.12.
Shares of Tabula Rasa HealthCare stock traded up $1.00 during trading on Friday, hitting $43.83. 185,326 shares of the company’s stock traded hands, compared to its average volume of 383,624. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.80 and a quick ratio of 1.73. Tabula Rasa HealthCare Inc has a 1 year low of $42.29 and a 1 year high of $91.16. The stock has a market capitalization of $963.73 million, a PE ratio of 128.91 and a beta of 1.51.
Tabula Rasa HealthCare (NASDAQ:TRHC) last released its quarterly earnings data on Wednesday, May 8th. The company reported ($0.14) EPS for the quarter, meeting the consensus estimate of ($0.14). Tabula Rasa HealthCare had a positive return on equity of 4.22% and a negative net margin of 18.15%. The company had revenue of $60.96 million for the quarter, compared to analysts’ expectations of $59.24 million. As a group, sell-side analysts expect that Tabula Rasa HealthCare Inc will post -0.55 EPS for the current fiscal year.
In other Tabula Rasa HealthCare news, President Orsula V. Knowlton sold 8,000 shares of the firm’s stock in a transaction dated Friday, May 17th. The stock was sold at an average price of $47.11, for a total value of $376,880.00. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Calvin H. Knowlton sold 8,270 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $53.68, for a total value of $443,933.60. The disclosure for this sale can be found here. Insiders sold 48,270 shares of company stock worth $2,565,774 over the last three months. Insiders own 14.00% of the company’s stock.
Tabula Rasa HealthCare Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.
Read More: How to Invest in Marijuana Stocks
Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.